Samlyn Capital »

Soleno Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 302k 40.25

More positions owned by Samlyn Capital

First Solar Call Option (FSLR)
Lpl Financial Holdings (LPLA)
Natera Call Option (NTRA)
Voya Financial (VOYA)
Kenvue Call Option (KVUE)
Vanguard Index Fds Large Cap Etf (VV)
Core & Main Cl A (CNM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Crocs (CROX)
Coca-cola Europacific Partne SHS (CCEP)
Take-Two Interactive Software (TTWO)
Merus N V (MRUS)
Planet Fitness Cl A (PLNT)

View all positions for Samlyn Capital

Top funds holding Soleno Therapeutics

Vivo Capital
Perceptive Advisors
Carlyle
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Wellington Management Company
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics